ARKG
ARK Genomic Revolution ETF · Financial Services · Asset Management
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 47 | 0 | 29.37M | $1.24B | +5 | −6 |
| Q1 2026 | 49 | 0 | 24.90M | $646.32M | +4 | −4 |
| Q4 2025 | 49 | +2 | 26.43M | $765.89M | +2 | — |
| Q3 2025 | 7 | +1 | 13.20M | $366.52M | +2 | −1 |
| Q2 2025 | 3 | +2 | 510.91K | $12.44M | +2 | — |
| Q1 2025 | 1 | -3 | 3.89K | $80,807 | — | −3 |
| Q4 2024 | 4 | 0 | 1.07M | $25.17M | — | — |
| Q3 2024 | 4 | 0 | 325.38K | $8.33M | — | — |
| Q2 2024 | 4 | — | 267.17K | $6.27M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 129.50K | — | $3.04M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Two Sigma Investments ✦ | 118.20K | — | $2.78M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 12.13K | — | $284,718 | 0.0% | n/c | 1 | SEC ↗ |
| 4 | ARK Investment Management ✦ | 7.34K | — | $172,347 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 219 holders, 21.49M shares, $567.76M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.